SciELO - Scientific Electronic Library Online

 
vol.31 issue2Generalities of the Treatment of Diabetic Macular Edema and the Use of StatinsVitamin D beyond Calcium Homeostasis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Endocrinología

On-line version ISSN 1561-2953

Abstract

MONTEAGUDO PENA, Gilda; HERNANDEZ ROMERO, Maidelys; GOMEZ ALZUGARAY, Manuel  and  OVIES CARBALLO, Gisel. Late-Onset Hypogonadism Treatment with Testosterone. Rev Cubana Endocrinol [online]. 2020, vol.31, n.2  Epub Nov 06, 2020. ISSN 1561-2953.

Introduction:

The use of testosterone replacement therapy in older men has increased in recent years, which has generated multiple controversies not yet resolved about its benefits and potential risks, especially those related to the development or worsening of the prostate or cardiovascular disease.

Methods:

A literature review was conducted with the aim of offering a state of the art that helps clinicians make decisions when considering testosterone treatment in patients with late-onset hypogonadism. The information search was carried out with the Google Scholar, Medline and Pubmed search engines.

Conclusions:

Testosterone treatment in late-onset hypogonadism is safe, rational, and evidence-based, but it is not recommended to offer it to all older men with low serum testosterone levels. It is advised in those with overt symptoms of androgen deficiency, without active prostate, breast or liver cancer, elevated hematocrit, benign prostatic hyperplasia with severe obstructive symptoms, untested prostate nodule or induration, prostate specific antigen> 4 ng / mL (or > 3 ng / mL in high-risk patients), severe untreated obstructive sleep apnea, short-term fertility wishes, uncontrolled heart failure, acute myocardial infarction or stroke in the last SIX months, or thrombophilia. It is recommended to carry out quarterly monitoring during the first year and then according to each case, which includes evaluation of the clinical response, of conditions that can be aggravated by treatment, and of laboratory parameters.

Keywords : late-onset hypogonadism; testosterone replacement therapy; testosterone and prostate; testosterone and cardiovascular disease.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )